IDEAYA Biosciences (IDYA) Change in Acquisitions & Divestments (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $162.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 12.78% year-over-year to $162.5 million; the trailing twelve-month figure through Mar 2026 stood at $656.4 million (down 13.15% YoY), and the FY2025 full-year result was $680.2 million, down 1.79% from the prior year.
• Change in Acquisitions & Divestments advanced to $162.5 million in Q1 2026, from $138.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $234.3 million in Q2 2024 to a low of $46.9 million in Q1 2022.
• A 5-year average of $129.5 million and a median of $133.8 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments slumped 38.38% in 2022 and soared 134.88% in 2024, its largest moves.
• Tracing IDYA's Change in Acquisitions & Divestments over 5 years: stood at $55.2 million in 2022, then surged by 100.09% to $110.5 million in 2023, then advanced by 27.63% to $141.0 million in 2024, then retreated by 1.48% to $138.9 million in 2025, then gained by 16.97% to $162.5 million in 2026.
• Business Quant data shows IDYA's Change in Acquisitions & Divestments at $162.5 million in Q1 2026, $138.9 million in Q4 2025, and $180.8 million in Q3 2025.